Literature DB >> 6319275

Primary structural sequence polymorphism in the human class II MHC antigen 33.1.

M C Kuo, X M Li, G E Marti, J A Sachs, J A Sogn, J E Coligan, T J Kindt.   

Abstract

Monoclonal antibody 33.1 defines a non-DR, class II, human major histocompatibility complex antigen, 33.1, which appears to be distinct from other class II antigens in its cellular distribution and primary structure. To characterize the structure more fully and to determine the degree of polymorphism within 33.1, a comparative N-terminal sequence study has been undertaken using a series of ten B lymphoblastoid cell lines with different DR and MB types. The results confirm that both the alpha and beta chains of 33.1 are homologues of the corresponding chains of the murine I-A antigen and indicate that while 33.1 does not appear to be identical with MB, it is closely related. Sequence analyses revealed two major variants of 33.1, corresponding to cells with specificities MB1 and MB3, respectively. Within each MB type, other polymorphisms have been detected. Cells that are MB2 do not react with monoclonal antibody 33.1. Suggestive evidence is presented that monoclonal antibody 33.1 reacts predominantly with the beta chain of the antigen. The preferential expression of 33.1 on activated B cells suggests that expression of at least the 33.1 beta chain gene is greatly enhanced in the course of B-cell activation, but the specific function of 33.1 remains to be determined.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6319275     DOI: 10.1007/bf00364473

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  35 in total

1.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

2.  Radiochemical sequence analysis of biosynthetically labeled proteins.

Authors:  J E Coligan; F T Gates; E S Kimball; W L Maloy
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

3.  The human HLA-DR antigens are encoded by multiple beta-chain loci.

Authors:  C K Hurley; G Nunez; R Winchester; O J Finn; R Levy; J D Capra
Journal:  J Immunol       Date:  1982-11       Impact factor: 5.422

4.  Peptide map comparisons of similar serologically defined HLA-DR antigens isolated from different lymphoblastoid cell lines.

Authors:  S M Goyert; R Gatti; J Silver
Journal:  Hum Immunol       Date:  1982-11       Impact factor: 2.850

5.  Analysis of the oligosaccharides on the HLA-DR and DC1 B cell antigens.

Authors:  D A Shackelford; J L Strominger
Journal:  J Immunol       Date:  1983-01       Impact factor: 5.422

6.  A homozygous human cell line contains three subsets of HLA-DR-like antigens distinguishable by amino acid sequencing.

Authors:  D W Andrews; M R Bono; J L Strominger
Journal:  Biochemistry       Date:  1982-12-21       Impact factor: 3.162

7.  Monoclonal antibodies defining serologically distinct HLA-D/DR related Ia-like antigens in man.

Authors:  L M Nadler; P Stashenko; R Hardy; J M Pesando; E J Yunis; S F Schlossman
Journal:  Hum Immunol       Date:  1981-02       Impact factor: 2.850

8.  Complete sequence of an HLA-dR beta chain deduced from a cDNA clone and identification of multiple non-allelic DR beta chain genes.

Authors:  E O Long; C T Wake; J Gorski; B Mach
Journal:  EMBO J       Date:  1983       Impact factor: 11.598

9.  Structural analysis of a human I-A homologue using a monoclonal antibody that recognizes an MB3-like specificity.

Authors:  R C Giles; G Nunez; C K Hurley; A Nunez-Roldan; R Winchester; P Stastny; J D Capra
Journal:  J Exp Med       Date:  1983-05-01       Impact factor: 14.307

10.  Demonstration of a third structurally distinct human Ia beta chain by two-dimensional gel electrophoresis.

Authors:  R W Karr; C C Kannapell; J A Stein; T C Fuller; R J Duquesnoy; G E Rodey; D L Mann; H M Gebel; B D Schwartz
Journal:  J Exp Med       Date:  1982-08-01       Impact factor: 14.307

View more
  3 in total

1.  Gene organization of DC and DX subregions of the human major histocompatibility complex.

Authors:  K Okada; J M Boss; H Prentice; T Spies; R Mengler; C Auffray; J Lillie; D Grossberger; J L Strominger
Journal:  Proc Natl Acad Sci U S A       Date:  1985-05       Impact factor: 11.205

2.  Specificity of the HLA class II reactive monoclonal antibody 33.1.

Authors:  X M Li; J A Sogn; J E Coligan; M C Kuo; G E Marti; L J Edison; T J Kindt
Journal:  Immunogenetics       Date:  1984       Impact factor: 2.846

3.  Identification of two cis-encoded HLA-DQ molecules that carry distinct alloantigenic specificities.

Authors:  J P Johnson; R Wank
Journal:  J Exp Med       Date:  1984-11-01       Impact factor: 14.307

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.